Haematogenous seeding in mycosis fungoides and Sézary syndrome: current evidence and clinical implications
British Journal of Dermatology · 2025
DOI: 10.1093/bjd/ljae441 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Dermatology, 2025. Verfasst von Robert Gniadecki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, University of Alberta, Edmonton, AB, Canada. Hauptthemen laut MEDLINE: Sezary Syndrome, Mycosis Fungoides, Skin Neoplasms, Neoplasm Seeding. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kyowa Kirin International plc, Swiss Cancer Research Foundation, Swiss National Science Foundation.
Abstract (Originalsprache)
Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of diseases characterized by abnormal neoplastic T-cell growth in the skin. Mycosis fungoides (MF), the most common CTCL, manifests as erythematous skin patches and/or plaques, tumours or erythroderma. The disease may involve blood, lymph nodes and rarely viscera. Sézary syndrome (SS) is a unique leukaemia/lymphoma syndrome related to MF, which presents with blood and skin involvement at diagnosis. The pathogenesis of MF/SS is not fully elucidated. The presence of skin lesions at distant sites underpins a hypothesis that MF/SS lesions may develop through haematogenous seeding. Phenotypic similarities between malignant and normal T cells led to the notion that disease-initiating mutations occur in specific subtypes of mature T cells, which are responsible for most CTCLs. However, this mature T-cell precursor model is not always consistent with clinical observations and research on MF/SS pathogenesis. Here, we review evidence supporting an alternative model of pathogenesis for MF/SS involving haematogenous seeding as a key process responsible for the initiation and progression of the disease. According to this hypothesis, malignant transformation occurs at an early stage of T-cell development (probably in bone marrow or thymus), yielding circulating neoplastic T cells which colonize the skin where the microenvironment is most permissive for proliferation and evolution. These mutated precursor cells seed the skin where they find a suitable niche to develop into clinically perceptible disease. Subsequently, malignant T cells can re-enter the bloodstream, re-seed pre-existing lesions and seed new areas of the skin, causing synchronous and convergent changes in the transcriptomic profile of lesions and tumours, and clinical disease progression – ‘consecutive haematogenous seeding’ captures this temporal phenomenon. This model radically changes the current understanding of CTCL pathogenesis, transforming it from a primarily cutaneous disease with secondary involvement of blood, to a systemic disease, where the spread of malignant cells through the blood to the skin is not a phenomenon of advanced disease but is an essential component of pathogenesis. This understanding of MF/SS could have several clinical implications, including standardizing our approach to assessing blood tumour burden, potential advances in prognosis and monitoring, and investigating combination treatments to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Dermatology, University of Alberta, Edmonton, AB, Canada.
- Department of Dermatology, Lausanne University Hospital and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
- University Institute and Clinic for Immunodermatology, Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
- Department of Pathology and Division of Dermatology, City of Hope Medical Center and Beckman Research Institute, Duarte, CA, USA.
- University Medical Center Mannheim/Ruprecht Karls University of Heidelberg, Mannheim, Germany.
- Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany.
ORCID-Profile: Emmanuella Guenova, Christiane Querfeld
Förderung
- Kyowa Kirin International plc
- Swiss Cancer Research Foundation
- Swiss National Science Foundation
- University of Lausanne
Zitieren
APA
Gniadecki, R., Guenova, E., Querfeld, C., Nicolay, J. P., Scarisbrick, J., & Sokol, L. (2025). Haematogenous seeding in mycosis fungoides and Sézary syndrome: current evidence and clinical implications. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae441
Vancouver
Gniadecki R, Guenova E, Querfeld C, Nicolay JP, Scarisbrick J, Sokol L. Haematogenous seeding in mycosis fungoides and Sézary syndrome: current evidence and clinical implications. British Journal of Dermatology. 2025. doi:10.1093/bjd/ljae441
BibTeX
@article{Gniadecki2025,
author = {Gniadecki, Robert and Guenova, Emmanuella and Querfeld, Christiane and Nicolay, Jan P and Scarisbrick, Julia and Sokol, Lubomir},
title = {Haematogenous seeding in mycosis fungoides and Sézary syndrome: current evidence and clinical implications},
journal = {British Journal of Dermatology},
year = {2025},
doi = {10.1093/bjd/ljae441}
}
EUVIMED